Chiral Cyclic Aliphatic Linkers as Building Blocks for Selective Dopamine D₂or D₃Receptor Agonists

Keyphrases

• Aliphatic Linkers 100%
• Bitopic 33%
• Bitopic Ligands 33%
• Design Approach 33%
• Dopamine 100%
• Dopamine D2 Receptor (DRD2) 33%
• Dopamine D3 Receptor 33%
• Drug Design 33%
• G Protein-coupled Receptor 66%
• Innovative Approach 33%
• Ligand-directed 33%
• Linker 66%
• Molecular Docking Studies 33%
• Optically Active 33%
• Pharmacology 66%
• Pharmacophore 33%
• Receptor Subtypes 33%
• Regio 33%
• Regiochemistry 33%
• Stereochemistry 66%
• Stereospecific 33%
• Subtype Selectivity 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Dopamine 3 Receptor 50%
• Dopamine Receptor D2 50%
• Dopamine Receptor Stimulating Agent 50%
• Drug Development 50%
• G Protein Coupled Receptor 100%
• Receptor Subtype 50%